J H Jorgensen - Publications, H-index & Citations

New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria

IF4.5

2008-12-01

109

OAAI

Prakash, V.; Lewis, J. S., II; Jorgensen, J. H.

The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis 蒙特卡罗模拟的药代动力学-药效学模型对脑膜炎奈瑟氏球菌易感性断点发展的贡献

IF7.3

2007-01-15

181

PREAI

Jorgensen, James H.; Hindler, Janet F.

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2007-01-01

OAAI

Burgess, D. S.; Frei, C. R.; Lewis, J. S., II; Fiebelkorn, K. R.; Jorgensen, J. H.

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument

Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae

IF5.4

2004-12-01

OAAI

Jorgensen, JH; Crawford, SA; McElmeel, LM; Whitney, CG

Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates

IF4.5

2003-09-01

OAAI

Restrepo, MI; Velez, JA; McElmeel, ML; Whitney, CG; Jorgensen, JH

Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome

IF7.3

2001-05-15

OAAI

Murray, CK; Walter, EA; Crawford, S; McElmeel, ML; Jorgensen, JH

Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae

IF7.3

2001-01-15

PREAI

Anstead, GM; Jorgensen, JH; Craig, FE; Blaser, MJ; Patterson, TF

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

IF4.5

2000-11-01

OAAI

Jorgensen, JH; Weigel, LM; Swenson, JM; Whitney, CG; Ferraro, MJ; Tenover, FC

AMERICAN JOURNAL OF PUBLIC HEALTH

IF9.6

2000-02-01

480

OAAI

Feikin, DR; Schuchat, A; Kolczak, M; Barrett, NL; Harrison, LH; Lefkowitz, L; McGreer, A; Farley, MM; Vugia, DJ; Lexau, C; Stefonek, KR; Patterson, JE; Jorgensen, JH

Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci

Development of an antimicrobial susceptibility testing method suitable for performance during space flight

IF4.5

1999-02-01

101

OAAI

Jorgensen, JH; Weigel, LM; Ferraro, MJ; Swenson, JM; Tenover, FC

In vitro susceptibility testing of Borrelia burgdorferi by a dialysis culture method

IF5.4

1997-08-01

OAAI

Jorgensen, JH; Skweres, JA; Mishra, SK; McElmeel, ML; Maher, LA; Mulder, R; Lancaster, MV; Pierson, DL

Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia

IF4.5

1997-05-01

OAAI

Dever, LL; Jorgensen, JH; Barbour, AG

Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae

IF5.4

1997-01-01

OAAI

Jorgensen, JH; Mirrett, S; McDonald, LC; Murray, PR; Weinstein, MP; Fune, J; Trippy, CW; Masterson, M; Reller, LB

In vivo activities of ceftriaxone and vancomycin against Borrelia spp in the mouse brain and other sites

IF5.4

1996-11-01

OAAI

Jorgensen, JH; Swenson, JM; Tenover, FC; Barry, A; Ferraro, MJ; Murray, PR; Reller, LB

Sample size could limit the power of case-control studies for determining risk factors for community-acquired methicillin-resistant Staphylococcus aureus - Reply

IF4.5

1996-11-01

OAAI

Kazragis, RJ; Dever, LL; Jorgensen, JH; Barbour, AG

Serogroup-specific epidemiology of Streptococcus pneumoniae: Associations with age, sex, and geography in 7,000 episodes of invasive disease

IF7.3

1996-10-01

OAAI

Moreno, F; Kelly, CC; Jorgensen, JH; Patterson, JE